Fieldpoint Private Securities, LLC Abb Vie Inc. Transaction History

Fieldpoint Private Securities, LLC

$344 Million
Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 28,999 shares of ABBV stock, worth $5.26 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

28,999

Previous 36,153 19.79%

Holding current value

$5.26 Million

Previous $5.86 Million 24.23%

% of portfolio

1.29%

Previous 1.21%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $984,533 - $1.25 Million	-7,154 Reduced 19.79%	28,999 $4.44 Million
Q1 2022 Apr 07, 2022	BUY	$131.98 - $163.75 $128,284 - $159,165	972 Added 2.76%	36,153 $5.86 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $40,930 - $51,789	381 Added 1.09%	35,181 $4.76 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $9,788 - $11,111	92 Added 0.27%	34,800 $3.75 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $149,398 - $166,438	1,420 Added 4.27%	34,708 $3.99 Million
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $254,420 - $280,085	-2,487 Reduced 6.95%	33,288 $3.6 Million
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $720,465 - $972,705	8,951 Added 33.37%	35,775 $3.83 Million
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $41,236 - $48,398	480 Added 1.82%	26,824 $2.35 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $858,282 - $1.15 Million	-11,698 Reduced 30.75%	26,344 $2.59 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $50,310 - $76,276	780 Added 2.09%	38,042 $2.9 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $1.34 Million - $1.68 Million	18,639 Added 100.09%	37,262 $3.3 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $9,824 - $11,812	-156 Reduced 0.83%	18,623 $1.41 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $117,865 - $150,660	1,794 Added 10.56%	18,779 $1.37 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $37,912 - $46,756	-487 Reduced 2.79%	16,985 $1.57 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $429,686 - $575,390	-4,670 Reduced 21.09%	17,472 $1.65 Million
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $107,024 - $117,360	-1,195 Reduced 5.12%	22,142 $2.14 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $80,816 - $103,227	1,157 Added 5.22%	23,337 $2.07 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,180	22,180 $1.61 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Account

Fieldpoint Private Securities, LLC Abb Vie Inc. Transaction History